Plus: AMD reports sharp increases in profit and sales. Rivian Automotive records a jump in third-quarter revenue. And Nintendo boosts guidance for the full year. Julie Chang hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Journal. - The Healthcare Fight at the Heart of the Shutdown
The debate over healthcare subsidies has shut down the federal government for a historic length of time. With open enrollment underway, many Americans who pay for plans under the Affordable Care Act are experiencing sticker shock. Some costs have doubled, tripled, or even quintupled. WSJ’s Anna Wilde Matthews takes us inside the hefty premium hikes and explains why the high price tag could have an impact on the system as a whole. Ryan Knutson hosts.
Further Listening:
-The Healthcare Costs of Trump's Big Beautiful Bill
-Medicare, Inc. Part 1: How Insurers Make Billions From Medicare
-Medicare Inc. Part 2: Taxpayers Paid for care Denied by Insurers
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Bulwark Podcast - Andy Beshear and Terry Moran: The Power of Normal People
With Trump slashing SNAP benefits, Gov. Beshear is asking the people of Kentucky to look out for their neighbors so they don't go hungry—since the administration won't. Meanwhile, Trump's tariffs are hammering farmers in the Bluegrass State at the same time Republicans are sabotaging rural healthcare. And reporting from Chicago, Moran finds his hometown still full of tough, independent people who won't be pushed around. True to form: Moms, bystanders, and priests are standing up to immigration agents while Trump tries to flex the full force of his authoritarian ambitions. Plus, Norah O'Donnell did not stand up for the truth, and the legacy and patriotism of Dick Cheney.
Gov. Andy Beshear and Terry Moran join Tim Miller.
show notes
Gov. Andy Beshear and Terry Moran join Tim Miller.
show notes
- The Bulwark's Special Election Night Coverage at 8ET
- Bill and JVL on the legacy of Dick Cheney
- Terry's Substack
- Terry's recent reporting from Chicago
- Andrew's recent interview with Iowa's Rob Sand
- To get 6 bottles of wine for $39.99, head to NakedWines.com/THEBULWARK and use code THEBULWARK for both the code AND PASSWORD.
In the Loop with Sasha-Ann Simons - U.S. Will Only Admit 7,500 Refugees A Year: ‘We Are So Disappointed’
The Trump administration is reducing the number of refugees allowed to enter the U.S. each year from 125,000 to 7,500 and prioritizing the admission of white South Africans, or Akrifaners. In the Loop learns what this means for local refugees from Mohammed, who is waiting to be reunited with his family, and Sally Schulze, communications manager at RefugeeOne.
For a full archive of In the Loop interviews, head over to wbez.org/intheloop.
Marketplace All-in-One - Friends, foes and tariffs
President Donald Trump’s tariffs have rattled the global economy this year. That goes for both allies and adversaries of the United States. But the future of some of these tariffs hinge on the outcome of a Supreme Court case challenging their legality. On today’s show, Asma Khalid, co-host of “The Global Story” podcast from the BBC, joins Kimberly to explain what’s at stake. Plus, how international relationships are shifting in the Trump era.
Here’s everything we talked about today:
- "The Global Story, The Supreme Court battle over Trump’s tariffs" from the BBC World Service
- "Geopolitics of Trump Tariffs: How U.S. Trade Policy Has Shaken Allies" from Council on Foreign Relations
- "The president who cried tariffs: will the US supreme court challenge Trump’s trade war?" from The Guardian
- "China and India pledge to be 'partners not rivals'" from BBC News
- "The rise and fall of globalisation: the battle to be top dog" from The Conversation
We love hearing from you. Leave us a voicemail at 508-U-B-SMART or email makemesmart@marketplace.org.
Federalist Radio Hour - Why Government-Run Groceries Will Never Work
On this episode of The Federalist Radio Hour, Dr. Anne Rathbone Bradley, the George and Sally Mayer fellow for economic education and vice president of academic affairs at The Fund for American Studies, joins Federalist Senior Elections Correspondent Matt Kittle to dissect New York City mayoral candidate Zohran Mamdani's government-run grocery store plan and explain the historical and economic reasons socialized food programs don't work.
If you care about combating the corrupt media that continue to inflict devastating damage, please give a gift to help The Federalist do the real journalism America needs.
If you care about combating the corrupt media that continue to inflict devastating damage, please give a gift to help The Federalist do the real journalism America needs.
Audio Poem of the Day - Composed upon Westminster Bridge, September 3, 1802
By William Wordsworth
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
WSJ Minute Briefing - Novo Nordisk, Pfizer Up Their Multibillion-Dollar Bids for Metsera
Plus: First Brands’ new management accuses founder Patrick James of fraud. And Stellantis’s Chrysler recalls over 300,000 hybrid Jeeps over battery fire risks. Zoe Kuhlkin hosts.
Sign up for WSJ’s free What’s News newsletter.
An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Learn more about your ad choices. Visit megaphone.fm/adchoices
WSJ What’s News - What’s News in Earnings: Who Is Winning the Obesity-Drug Arms Race?
Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump’s drug-pricing plans, including TrumpRx.
WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies’ earnings reports and analyst calls to find out what’s going on under the hood of the American economy.
Sign up for the WSJ's free Markets A.M. newsletter.
Further Reading:
Novo Nordisk Sweetens Offer for Metsera - WSJ
Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal
Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk
The Day Pharma’s Weight-Loss Gold Rush Intensified
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand
Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera
Novo Nordisk to Shake Up Board After Obesity-Market Challenges
Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings
AbbVie Lifts Profit Outlook as Sales Rise
Bristol Myers Squibb Profit Soars, Raises Revenue Guidance
Merck Profit Rises on Strong Keytruda Demand
GSK Lifts Guidance After Specialty Medicines Boost Sales
Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead
Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise
J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains
Learn more about your ad choices. Visit megaphone.fm/adchoices
Global News Podcast - Former US Vice-President Dick Cheney dies
Dick Cheney, who became one of the most powerful vice presidents in US history as George W Bush's number two during 9/11 and the wars in Afghanistan and Iraq, died Monday. He was 84. Also: Sudan's military government meets to discuss its response after its last stronghold in the Darfur region was seized by paramilitaries; New Yorkers vote for their next Mayor, and scientists in Kenya find evidence that the first humans used stone tools.
The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk